Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page now indicates recruitment is closed and introduces new user-guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), plus a revision notice.SummaryDifference0.3%

- Check8 days agoChange DetectedThe page shows a revision update from v3.5.4 to v3.5.5, indicating a small maintenance update to the study record page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision tag, Revision: v3.5.4, was added and the previous Revision: v3.5.3 was removed, indicating a version update for the study record.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page’s footer software revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check73 days agoChange DetectedUpdated the listed location from Padua, Italy to Padova, Italy to reflect the official local name and maintain consistency in the site listings.SummaryDifference0.0%

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.